In partnership with
October 13, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Today’s edition is brought to you by 1440 Media, the five-minute daily read trusted by millions who want facts without spin. Stay informed - click the links and level up before your next meeting.
A new episode of The Hybrid drops this week, and you won’t want to miss it.
Our Read-In doubles as today’s Decoded Insight, because what’s happening at Target may reshape how hemp and marijuana coexist, and who controls the future of cannabinoid beverages. The pilot looks like progress, but the fine print tells a deeper story about balance sheets, slotting fees, and who actually survives once mainstream retail decides to play.
🏪 Target’s hemp pilot stresses balance sheets, not beverages
📈 Retail data, slotting fees, and market consolidation ahead
🌿 Hemp’s biggest test yet for legitimacy and survival
Where regulation meets real-world leverage.
Looking for unbiased, fact-based news? Join 1440 today.
Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.
The deeper pattern behind today’s moves — and why it matters next.
📌 What Happened: Target launched a 12-brand hemp THC beverage pilot across 10 Twin Cities stores, following Total Wine and Spec's into a Minnesota market where these drinks now represent 15% of liquor store sales just two years after launch (Reuters). The pilot exploits Minnesota's uniquely permissive hemp framework, where some distributors move more hemp drinks than wine and spirits combined, with cannabis beverage margins running higher than beer or spirits and wholesale-to-retail markups hovering around 100%. The participating brands are celebrating institutional validation. If Target stocks you, you're legitimate. Target's actual objective runs counter to that optimism. The company isn't testing consumer demand, they already know consumers want this. Target is testing which brands can afford to stay on their shelves, and the brand selection tells you exactly what Target already concluded. They picked cannabis MSOs with billion-dollar market caps (Green Thumb Industries' Señorita, Canopy Growth's Wynk), major VC-backed cannabis brands (Wyld, Cann), established Minnesota craft breweries with existing Target vendor relationships (Surly, Indeed), and a handful of regional hemp startups (Birdie, Gigli, Stigma, Trail Magic, Wonder, Hi Seltzer) to fill out the test (Marijuana Moment). The MSOs and breweries will survive. The startups are paying to validate the category for companies that can actually afford what comes next.
💡 Why It Matters: The pattern is structural across CPG categories that made this transition: 85% of new CPG products fail within two years, 80-90% of founders never reach sustainability, only 10-20% of brands exceed $1 million in revenue, and most failures occur within 2-3 years of mainstream retail entry (Metrics Cart). Energy drinks offer the clearest example. Red Bull and Monster leveraged big-box partnerships into a 70% global duopoly, strategic distribution agreements locked smaller brands out of shelf space, and anyone who built market share got acquired before establishing independence (Tennessee Law Review). Hard seltzer looked different until it didn't: White Claw and Truly exploded through grocery distribution, every major alcohol company entered, Boston Beer's demand miscalculation destroyed millions of cases and paid contract brewers millions in penalties, while White Claw maintained dominance through established retail relationships as late entrants got buried (The Drinks Business). The brands aren't the only ones who should be sweating. Liquor stores built Minnesota's hemp beverage market from nothing, took the regulatory risk when nobody knew if the category was legal, educated consumers about dosing and effects, and now represent 15% of their sales from a product that didn't exist two years ago. Target just walked in and took their customer base. Parents are always at Target anyway, picking up groceries and household items, and if they can grab a four-pack of hemp drinks in the same trip instead of making a separate stop at a liquor store, that's exactly what they'll do. Liquor stores competed on selection and expertise. Target competes on convenience and trips you're already making. Here's what happens next with Target's pilot. The company generates velocity data identifying top performers, then approaches them with scaling proposals. Slotting fees start at $10,000+ per SKU and increase by region (Vispera). Co-op advertising takes 2-5% of net sales. Brands fund promotions weeks before retail sales arrive. Payment terms stretch to Net-60 or Net-90, meaning you finance Target's inventory with your working capital. Compliance violations trigger penalties exceeding profit on entire shipments.
🧠 THC Group Take: Hemp beverage brands celebrating Target's entry are making the same mistake early cannabis operators made: thinking retail access is the finish line instead of the starting gun for who actually controls market power. Sure, you'd rather be Anheuser-Busch than Total Wine, manufacturing at scale with established brands beats owning shelf space. But look at Target's brand selection and you'll see they already know which category wins. Green Thumb Industries and Canopy Growth are publicly traded cannabis companies with market caps over $1 billion. Wyld and Cann raised tens of millions in venture funding. Surly and Indeed are established Minnesota craft breweries that already supply Target with beer, meaning they understand Target's compliance systems, have existing vendor relationships, and know exactly what margin compression looks like because they've been living it for years. Then you have the regional hemp startups, which exist in this pilot to provide category diversity while the brands with actual capital demonstrate whether the economics work.
Target's pilot is a balance sheet stress test, and they pre-selected brands they know can pass it. The MSOs have infinite capital relative to slotting fees. The breweries have existing infrastructure and vendor status. The VC-backed brands raised money specifically to survive this kind of distribution gauntlet. The regional startups are about to discover what the other brands already know: retail access costs more than they budgeted.
Brands without venture backing or MSO balance sheets face a circular problem. Allocate capital to slotting fees and you lack funds for promotional support necessary to generate shelf velocity. Underfund promotion and product sits, Target pulls you for non-performance, you've paid to destroy your brand. Independent grocers deliver margins 10% higher than national chains, but you cannot build a scalable business selling to fragmented independents when Target offers volume (Swiftly). Except the volume comes at wholesale prices below what you're getting from independents. Private label competition arrives the moment Target has sales data. Across 225 CPG categories, private labels trended upward 86% of the time, retailers now control roughly 25% of sector spending, and they undercut name brands by 3-27% using your sales data to identify exactly what to replicate (UPenn - Wharton).
Regulatory uncertainty cuts against brands, not for them. They assume Target's entry demonstrates confidence in hemp's legal durability. Retailers face zero consequence for dropping entire categories overnight if frameworks change. When Ohio's governor banned hemp beverages via emergency order, retailers pulled product same-day and brands ate inventory loss. Target will do the same if federal enforcement shifts, except now you've restructured your entire business around their volume with no fallback.
The craft breweries in Target's pilot understand something the hemp startups don't: you don't celebrate when a big-box retailer gives you shelf space, you calculate whether you can afford to stay there. Surly and Indeed have been playing this game with Target for years. They know the promotional calendars, the margin expectations, the compliance penalties. They're not in this pilot because they're excited about validation, they're in it because they have existing vendor relationships and production capacity to absorb another SKU without restructuring their business. The MSOs are in it because they have the capital to treat this as a strategic option on future beverage market share. The VC-backed brands are in it because their investors specifically funded national retail expansion. The regional hemp startups? They're in it because Target needed to fill out the test, and they'll learn soon enough whether they can afford to stay.
Fast-moving headlines, flagged for what matters.
Republican Senators are discussing federal legislation to explicitly ban marijuana users from gun ownership as the Supreme Court considers whether to hear a challenge to the existing prohibition under Section 922(g)(3). The conversation follows circuit splits on whether the ban violates Second Amendment rights post-Bruen, with the Fifth Circuit ruling it unconstitutional while other circuits upheld it. GOP senators want to codify the ban legislatively rather than risk the Court striking it down entirely, which would prevent states from enforcing any firearm restrictions on cannabis users even in legal markets. The move reflects conservative positioning: maintain marijuana prohibition through gun policy even as public support for legalization exceeds 70% and most states have reformed their laws. Legislative action before a Supreme Court decision would moot the constitutional challenge while forcing Democrats to either vote against gun restrictions or vote to maintain federal marijuana prohibition through firearms policy, creating exactly the kind of wedge issue Republicans prefer when they cannot win the direct legalization debate. (Marijuana Moment)
Senator Thom Tillis (R-NC) told McClatchy he supports creating federal marijuana regulations that would allow states to "opt in" to legalization while establishing a federal excise tax and product standards, stating "I'm not an anti-cannabis person, but you've got to do it legally." The proposal comes after months of Tillis raising concerns about the Eastern Band of Cherokee Indians operating cannabis dispensaries in North Carolina with marketing campaigns extending to Charlotte, though the tribal chief pushed back saying EBCI operations are "fully compliant with federal and tribal law." Tillis represents the emerging Republican position that prohibition has failed but legalization requires guardrails - a framework that could actually pass a divided Congress where full legalization cannot. The tribal catalyst creates a conservative permission structure where Republicans can support federal regulation to prevent "chaos" rather than to enable state experimentation, and once FDA has authority over THC products and Treasury is collecting revenue, the opt-in model becomes largely theoretical since federal regulatory infrastructure operates regardless of state participation. (Marijuana Moment)
Gov. Mike DeWine issued an emergency health order banning intoxicating hemp sales starting next Tuesday, but Republican legislators who stripped his emergency powers during COVID limited such orders to 60 days unless the legislature votes to extend them - and one GOP representative already plans to introduce a repeal resolution after 30 days. DeWine displayed knock-off THC candies mimicking popular brands and cited rising pediatric hospitalizations, arguing "it is absolutely absurd that a 14-year-old, 13-year-old, can walk in the store and buy this stuff," while the Senate passed a bill in May channeling hemp products to dispensaries with exceptions for beverage sales at alcohol retailers. Three businesses sued Thursday claiming DeWine lacks authority for the ban, leaving companies like Cann - a nationally distributed hemp beverage with age restrictions - planning to warehouse inventory until the legal and legislative dust settles. DeWine accidentally handed hemp opponents exactly 60 days to force the House to pass the Senate's compromise bill or watch the ban expire, and the irony of Republicans who neutered executive authority during lockdowns now deciding whether to save DeWine's hemp crackdown will determine whether Ohio's gray market survives or gets shoved into dispensaries where adult-use operators have been bleeding cash for months. (Signal Ohio)
Minnesota's Office of Cannabis Management issued guidance allowing hemp THC beverage and edible manufacturers in good standing to continue selling products while new license applications are processed, addressing industry concerns that testing requirements and limited lab capacity could force business disruptions when stricter regulations take effect January 1. Manufacturers must apply for new licenses by October 31, but OCM Director Eric Taubel acknowledged the office didn't hear industry concerns during the legislative session when statutory fixes could have been made. Minnesota accidentally created the perfect regulatory stress test: the state authorized hemp THC sales in 2022 allowing explosive market growth, then passed comprehensive cannabis legislation requiring licensure and testing without building sufficient testing infrastructure first. Regulators are learning what Massachusetts discovered in 2018: you cannot phase in compliance requirements faster than your administrative capacity to process them, so agencies either grant transition relief or watch compliant businesses shut down due to bureaucratic bottlenecks rather than safety failures. (Star Tribune)
Texas Alcoholic Beverage Commission proposed hemp rules that would automatically revoke businesses' liquor licenses for hemp age-verification violations, prompting Total Wine's senior VP to argue penalties should target hemp licenses instead of imperiling unrelated alcohol permits. The draft regulations require ID checks for every hemp THC purchase regardless of apparent age and lack clear due process mechanisms for contesting violations, which stakeholders say violates the Texas Administrative Procedure Act. Hemp Business Council's executive director called the approach "heavy handed" with a "chilling effect or de facto ban" that gives retailers cause to stop carrying products entirely. Texas accidentally created the only scenario where Big Alcohol and hemp operators have identical regulatory interests - both need enforcement structures that don't destroy existing business infrastructure over compliance mistakes - and the liquor license revocation threat ensures major retailers will simply exit hemp rather than risk their core alcohol revenue streams. (Marijuana Moment)
Alabama's ABC Board approved implementation rules for the state's new hemp law but eliminated a requirement that would have forced retailers to keep hemp beverages in locked cases requiring employee access, after grocers argued the mandate would be "extremely costly" for small stores to staff. The board also clarified that pull-tab cans meet child-resistant packaging requirements for hemp-infused beverages under federal beverage standards, walking back stricter interpretations. The changes came after retail advocates pushed back on compliance burdens, though beverages must still be segregated in designated store areas away from children's products with clear hemp signage. Alabama originally writing regulations that assumed hemp beverages needed dispensary-style controls shows how alcohol regulators default to cannabis retail models even when regulating products that belong in the beer cooler, and grocers won this round because they had existing political relationships with ABC boards that hemp-only operators lack. (Alabama Daily News)
Curaleaf argues New Jersey's mandatory labor peace agreements for cannabis licensees violate the National Labor Relations Act, following the state Cannabis Regulatory Commission's 2023 threat to revoke the MSO's licenses over alleged union-busting. The legal challenge mirrors successful Oregon litigation where a federal judge ruled labor peace mandates preempt NLRA, prompting Oregon's liquor commission to stop requiring such agreements. Curaleaf's legal strategy represents the industry's continued failure to understand that labor could be their most powerful political ally - unions provide legitimacy with Democratic lawmakers who control most legal markets and create trained workforces that improve compliance. Fighting labor peace agreements in court while the industry needs Congressional rescheduling, banking access, and federal legalization is tactically insane, spending legal fees to alienate the only organized political force that consistently supports cannabis reform while battling alcohol distributors, pharmaceutical companies, and prohibition advocates. (Law360)
Ayr Wellness announced a restructuring support agreement and Article 9 proceedings under the Companies' Creditors Arrangement Act, becoming the latest multi-state operator to restructure debt it cannot service under current market conditions. The Massachusetts-based MSO operates 80+ dispensaries across nine states but faces the same problem as Curaleaf, Cresco, and other MSOs who expanded aggressively when capital was cheap: revenue growth stalled while debt service obligations didn't. Article 9 proceedings under Canadian bankruptcy law allow debt restructuring while maintaining operations, giving Ayr more flexibility than U.S. Chapter 11 since it's incorporated in Canada. The restructuring will convert debt to equity, dilute existing shareholders, and give lenders operational control, following the pattern where bondholders become owners and founders lose their companies. Federal prohibition forced cannabis companies into expensive debt instead of traditional bank financing, then state market saturation eliminated the growth needed to service those obligations, and now Ayr joins the growing list of MSOs discovering that operating dispensaries across nine states doesn't help if none generate enough margin to cover debt payments. (Cannabis Business Times)
A 23-expert panel published consensus competencies for teaching medical students about cannabis, recommending 8-10 hours woven into existing pharmacology and clinical courses rather than standalone electives. The six domains cover endocannabinoid biology, legal frameworks, therapeutic evidence, risk assessment, and clinical management, addressing the gap where only 9% of medical schools mentioned cannabis in 2015-2016 despite nearly 4 million registered patients across 38 states. Physicians currently dodge patient questions about dosing, drug interactions, and therapeutic fit, leaving patients to rely on budtenders and Reddit threads. The framework matters because dispensary staff nationwide are practicing medicine without licenses because doctors won't engage, and now medical schools are finally acknowledging that pretending cannabis doesn't exist creates liability gaps when patients ask legitimate therapeutic questions their physicians refuse to answer. (JAMA Network Open)
From the hearing room to the comment section — we’re watching it all.
🏥 Arkansas's medical marijuana program hit 100,761 patients while generating $283 million in sales and $40 million in taxes, which actually makes adult-use legalization harder because existing operators profit from limited competition and legislators like the current revenue without market disruption. Medical scarcity works fine for licensees and budget writers, even if patients want broader access. (The Marijuana Herald)
🚗 Ohio Traffic Safety Office is expanding "Shifting Gears," a program teaching high schoolers how THC affects developing brains and driving ability, addressing student misconceptions like "it makes me a better driver." The AAA Northeast curriculum delivered through Students Against Destructive Decisions follows the classic drug education playbook that's shown limited effectiveness - decades of research on D.A.R.E. and similar programs found they don't reduce substance use and sometimes increase experimentation by making drugs seem more interesting, so Ohio's bet that lectures about impairment will change teenage behavior ignores what actually works: honest conversations about risk, harm reduction strategies, and addressing why teens use substances in the first place. (10TV Columbus)
💼 Democratic Sen. Tina Polsky filed legislation prohibiting Florida public employers from firing medical marijuana patients unless cannabis impairs job performance, requiring five days notice before adverse action on positive THC tests. Polsky has filed similar bills repeatedly in the GOP-controlled Legislature without movement, and her latest version covers only public employees rather than all 895,469 qualified patients - the nation's largest medical marijuana population. (Miami Times)
🎬 The Sisters of the Valley, California's self-proclaimed cannabis nuns who grow hemp on a Merced farm, landed a cameo in Paul Thomas Anderson's film One Battle After Another starring Leonardo DiCaprio after Sister Kate rudely dismissed the director during a 2021 pandemic location scout for being maskless. The order's revenue dropped from $1.2 million pre-pandemic to $350,000 in 2024 due to California's tax burden and regulatory tangle, forcing them to partner with LA-based Traditional to grow high-THC products for Catalyst dispensaries starting November while maintaining their spiritual cultivation practices including salt protection circles around crops. (The Times (UK))